DJIA 18,285.74 0.34 0.00%
NASDAQ 5,090.79 19.05 0.38%
S&P 500 2,130.82 4.97 0.23%
market minute promo

Celgene (NASDAQ: CELG)

116.20 -0.66 (-0.56%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $116.20 -0.56%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $116.40
Previous Close $116.86
Daily Range $115.95 - $117.48
52-Week Range $73.60 - $129.06
Market Cap $92.2B
P/E Ratio 40.02
Dividend (Yield) $0.00 (0.0%)
Volume 3,923,870
Average Daily Volume 5,092,829
Current FY EPS $4.11

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

What Is the S&P 500 Index?

The S&P 500 Index and its component stocks.

Jim Cramer Answers Your Twitter Questions on Tesla, Jarden, Williams-Sonoma, Wayfair

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data, Achillion Signs Deal with J&J - Analyst B

Biotech Stock Roundup: Eleven Bio Slumps on Eye Drug Data, Achillion Signs Deal with J&J - Analyst Blog

10 S&P 500 Companies to Have the Most Revenue Growth in 2015

How Celgene Stock Is Breaking All the Rules

Celgene Corp. might look grossly overvalued based on its fundamentals. But a deeper look inside the company shows why the stock remains a compelling buy, despite its monstrous five-year run.

Agios Gains on Fast Track Status for Leukemia Drug AG-120 - Analyst Blog

Celgene/Accelreon's Luspatercept Granted Fast Track Status - Analyst Blog

Biosimilars Vs Generics: History Does Not Repeat, It Rhymes

Trillium Therapeutics - A Compelling Investment At Current Levels

Celgene's Crohn's Disease Drug Prompts Lingering Questions

See More CELG News...

CELG's Top Competitors

CELG $116.20 (-0.56%)
Current stock: CELG
GILD $111.22 (0.95%)
Current stock: GILD
AMGN $163.84 (-0.09%)
Current stock: AMGN
$0.00 (0.00%)
Current stock: